Clinical Trial

A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes

Name: A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes — clinical trial record (NCT07568678)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated May 6, 2026 (before its estimated August 13, 2026 completion). Its status may not reflect the trial's current state.

Summary

The study is to assess the safety, pharmacokinetics, and pharmacodynamic profile of HMS1005 in patient with diabetes

Trial Details

NCT Number	NCT07568678
Lead Sponsor	Hua Medicine Limited Collaborators: TigerMed
Conditions	Type 2 Diabetes
Enrollment	40 participants
Start Date	2025-12-04
Primary Completion	2026-08-13 (estimated)
Study Completion	2026-10-13 (estimated)
Updated on ClinicalTrials.gov	2026-05-06